Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Demographics and outcomes of hemoglobin genotype in hospitalized patients with COVID-19 and sickle cell disease in the United States.

European journal of haematology - 1 Oct 2023

Ilerhunmwuwa Nosakhare Paul, Inyang Lawrence, Wasifuddin Mustafa, Aiwuyo Henry, Tahir Muhammad, Hakobyan Narek, Ankah Paul, Torere Beatrice E, Amaechi Uchenna M, Rayapureddy Aditya Keerthi, Wang Jen Chin

Abstract excerpt

INTRODUCTION: Coronavirus disease 2019 (COVID-19) is associated with poor outcomes in sickle cell disease (SCD) patients. However, there is a paucity of data comparing hemoglobin (Hb) genotypes in SCD and infection outcomes. METHODS: The National Inpatient Sample was used to identify the record of hospitalizations with COVID-19 and SCD in 2020 using the International Classification of Disease, Tenth Revision...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anemia, Sickle Cell
Share to COVID-19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Demography

Share to Genotype

Share to Hemoglobin, Sickle

Share to United States

Source

Identifiers

PMID: 37477175
DOI: 10.1111/ejh.14054

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Demographics and outcomes of hemoglobin genotype in hospitalized patients with COVID-19 and sickle cell disease in the United States.PMID 37477175Read ↗

Genotype Differences and Hydroxyurea Utilization Among Adults With Moderate to Severe Sickle Cell Disease.Semantic proximity Read ↗

Prognostic factors associated with COVID-19 related severity in sickle cell disease.Semantic proximity Read ↗

Clinical Spectrum of Sickle Cell Disease and COVID-19: Laboratory and Clinical Factors Associated with Morbidity and MortalitySemantic proximity Read ↗

Hb S/β-Thalassemia in the REDS-III Brazil Sickle Cell Disease Cohort: Clinical, Laboratory and Molecular Characteristics.Semantic proximity Read ↗

The Accuracy of Hospital ICD-9-CM Codes for Determining Sickle Cell Disease GenotypeSemantic proximity Read ↗

Clinical and genetic ancestry profile of a large multi-centre sickle cell disease cohort in Brazil.Semantic proximity Read ↗

Comparative study of sickle cell anemia and hemoglobin SC disease: clinical characterization, laboratory biomarkers and genetic profilesSemantic proximity Read ↗

Accurate identification of sickle cell disease cases in a large genotyped cohort using electronic health record data.Semantic proximity Read ↗

Association of Kidney Comorbidities and Acute Kidney Failure With Unfavorable Outcomes After COVID-19 in Individuals With the Sickle Cell TraitSemantic proximity Read ↗

COVID-19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNetSemantic proximity Read ↗

Sickle Cell Disease and COVID-19: Susceptibility and SeveritySemantic proximity Read ↗

Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.